Rite Aid Sales Slow With OTC Claritin, HRT Slump; Growing Rx Count Is Focus
Executive Summary
Rite Aid is attributing its slower growth in prescription drug sales to reduced hormone therapy demand and the Claritin OTC switch
You may also be interested in...
Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering
Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005
Rite Aid Eyes Eckerd Customers During Transition; Profits Recovering
Rite Aid believes its new drug distribution contract with McKesson will bolster the chain's turnaround heading into fiscal 2005
Rx Market Starts Slow In 2003; IMS Still Confident Of Double-Digit Growth
IMS Health remains confident that the overall pharmaceutical market will grow in the double digits during 2003 despite the market's slow start